new BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 2251 hits with Last Name = 'ferguson' and Initial = 'r'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451823
PNG
(CHEMBL2112840)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(CC6CC6)CCC14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:23,THB:3:4:17:9.15.14,10:9:17:4.5.6|
Show InChI InChI=1S/C26H31NO9/c28-15-5-3-12-9-14-13-4-6-16(34-25-20(31)18(29)19(30)22(36-25)24(32)33)23-26(13,17(12)21(15)35-23)7-8-27(14)10-11-1-2-11/h3-6,11,13-14,16,18-20,22-23,25,28-31H,1-2,7-10H2,(H,32,33)/t13-,14+,16-,18-,19-,20-,22+,23-,25+,26?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.0600n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL




Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125686
PNG
(2-[10-hydroxy-4-methyl-(5R,13R,14S,17R)-12-oxa-4-a...)
Show SMILES CC1OC(O[C@H]2C=C[C@H]3[C@H]4Cc5ccc(O)c6O[C@@H]2C3(CCN4C)c56)C(O)C(O)C1O |c:6,TLB:23:22:8:24.11.10|
Show InChI InChI=1S/C23H29NO7/c1-10-17(26)18(27)19(28)22(29-10)30-15-6-4-12-13-9-11-3-5-14(25)20-16(11)23(12,21(15)31-20)7-8-24(13)2/h3-6,10,12-13,15,17-19,21-22,25-28H,7-9H2,1-2H3/t10?,12-,13+,15-,17?,18?,19?,21-,22?,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.170n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451820
PNG
(CHEMBL3085267)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:21,TLB:10:9:16:4.5.6|
Show InChI InChI=1S/C25H29NO9/c1-2-8-26-9-7-25-12-4-6-15(33-24-19(30)17(28)18(29)21(35-24)23(31)32)22(25)34-20-14(27)5-3-11(16(20)25)10-13(12)26/h2-6,12-13,15,17-19,21-22,24,27-30H,1,7-10H2,(H,31,32)/t12-,13+,15-,17-,18-,19-,21+,22-,24+,25-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.200n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451826
PNG
(CHEMBL2112797)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])CC[C@@H]2O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)ccc3O |THB:3:4:14:9.12.11,10:9:14:4.5.6|
Show InChI InChI=1S/C23H31NO8/c1-24-7-6-23-11-3-5-14(30-22-19(29)18(28)17(27)15(9-25)31-22)21(23)32-20-13(26)4-2-10(16(20)23)8-12(11)24/h2,4,11-12,14-15,17-19,21-22,25-29H,3,5-9H2,1H3/t11-,12+,14-,15-,17+,18-,19-,21-,22+,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.210n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451822
PNG
(CHEMBL2112839)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])CC[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |THB:10:9:14:4.5.6,3:4:14:9.12.11|
Show InChI InChI=1S/C23H29NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2,4,10-11,13,15-17,19-20,22,25-28H,3,5-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17-,19+,20-,22+,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.25n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL




Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451819
PNG
(CHEMBL2079659)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2OC1OC(CO)[C@H](O)C(O)C1O)ccc3O |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C23H29NO8/c1-24-7-6-23-11-3-5-14(30-22-19(29)18(28)17(27)15(9-25)31-22)21(23)32-20-13(26)4-2-10(16(20)23)8-12(11)24/h2-5,11-12,14-15,17-19,21-22,25-29H,6-9H2,1H3/t11-,12+,14-,15?,17-,18?,19?,21-,22?,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.280n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125690
PNG
(6-[10-hydroxy-4-methyl-(5R,13R,14S,17R)-12-oxa-4-a...)
Show SMILES CN1CCC23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4OC1CCCC(O1)C(O)=O)ccc5O |c:16,THB:0:1:12:8.9.10|
Show InChI InChI=1S/C23H27NO6/c1-24-10-9-23-13-6-8-16(28-18-4-2-3-17(29-18)22(26)27)21(23)30-20-15(25)7-5-12(19(20)23)11-14(13)24/h5-8,13-14,16-18,21,25H,2-4,9-11H2,1H3,(H,26,27)/t13-,14+,16-,17?,18?,21-,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.510n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125687
PNG
(2-[14-(6-carboxy-3,4,5-trihydroxytetrahydro-2H-2-p...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@@H](C[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C23H27NO8/c1-24-7-6-23-11-3-5-15(30-22-18(27)14(26)9-16(31-22)21(28)29)20(23)32-19-13(25)4-2-10(17(19)23)8-12(11)24/h2-5,11-12,14-16,18,20,22,25-27H,6-9H2,1H3,(H,28,29)/t11-,12+,14-,15-,16-,18-,20-,22+,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.600n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50000092
PNG
((-)-(etorphine) | (-)-morphine | (1S,5R,13R,14S)-1...)
Show SMILES CN1CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4O)ccc5O |r,c:16,TLB:13:12:8.9.10:3.2.1|
Show InChI InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
KEGG
MMDB
PC cid
PC sid
PDB
UniChem

Patents

PubMed
0.780n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125689
PNG
(6-[4-allyl-10-hydroxy-(5R,13R,14S,17R)-12-oxa-4-az...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])NCC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:18|
Show InChI InChI=1S/C22H25NO9/c24-11-3-1-8-7-10-9-2-4-12(19-22(9,5-6-23-10)13(8)17(11)31-19)30-21-16(27)14(25)15(26)18(32-21)20(28)29/h1-4,9-10,12,14-16,18-19,21,23-27H,5-7H2,(H,28,29)/t9-,10+,12-,14-,15-,16-,18+,19-,21+,22-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
0.980n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451824
PNG
(CHEMBL2092968)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])C=C[C@@H]2OC1OC(CO)[C@H](O)C(O)C1O)ccc3O |c:19,THB:3:4:14:9.12.11,10:9:14:4.5.6|
Show InChI InChI=1S/C23H29NO8/c1-24-7-6-23-11-3-5-14(30-22-19(29)18(28)17(27)15(9-25)31-22)21(23)32-20-13(26)4-2-10(16(20)23)8-12(11)24/h2-5,11-12,14-15,17-19,21-22,25-29H,6-9H2,1H3/t11-,12+,14-,15?,17-,18?,19?,21-,22?,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
1.20n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL




Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125680
PNG
(3,4-dihydroxy-2-[10-hydroxy-4-methyl-(5R,13R,14S,1...)
Show SMILES CN1CCC23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4OC1OC(=CC(O)C1O)C(O)=O)ccc5O |c:16,23,THB:0:1:12:8.9.10|
Show InChI InChI=1S/C23H25NO8/c1-24-7-6-23-11-3-5-15(30-22-18(27)14(26)9-16(31-22)21(28)29)20(23)32-19-13(25)4-2-10(17(19)23)8-12(11)24/h2-5,9,11-12,14-15,18,20,22,25-27H,6-8H2,1H3,(H,28,29)/t11-,12+,14?,15-,18?,20-,22?,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
1.40n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50370478
PNG
(MORPHINE-6-GLUCURONIDE | Morphine 6-Glucuronide(Mi...)
Show SMILES CN1CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)ccc5O |r,c:16|
Show InChI InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
Purchase

KEGG
PC cid
PC sid
UniChem
PubMed
1.5n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451825
PNG
(CHEMBL2113393)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)C(O)=O)ccc3O |r,c:19,THB:3:4:14:9.12.11,10:9:14:4.5.6|
Show InChI InChI=1S/C22H25NO8/c1-23-7-6-22-10-3-5-13(29-21-16(26)15(25)18(31-21)20(27)28)19(22)30-17-12(24)4-2-9(14(17)22)8-11(10)23/h2-5,10-11,13,15-16,18-19,21,24-26H,6-8H2,1H3,(H,27,28)/t10-,11+,13-,15-,16+,18-,19-,21+,22?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
1.60n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125692
PNG
(3,4,5-trihydroxy-6-[10-hydroxy-(5R,13R,14S,17R)-12...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2OC1O[C@H](CC(O)C1O)C(O)=O)ccc3O |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C23H27NO8/c1-24-7-6-23-11-3-5-15(30-22-18(27)14(26)9-16(31-22)21(28)29)20(23)32-19-13(25)4-2-10(17(19)23)8-12(11)24/h2-5,11-12,14-16,18,20,22,25-27H,6-9H2,1H3,(H,28,29)/t11-,12+,14?,15-,16+,18?,20-,22?,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
1.90n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451826
PNG
(CHEMBL2112797)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])CC[C@@H]2O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)ccc3O |THB:3:4:14:9.12.11,10:9:14:4.5.6|
Show InChI InChI=1S/C23H31NO8/c1-24-7-6-23-11-3-5-14(30-22-19(29)18(28)17(27)15(9-25)31-22)21(23)32-20-13(26)4-2-10(16(20)23)8-12(11)24/h2,4,11-12,14-15,17-19,21-22,25-29H,3,5-9H2,1H3/t11-,12+,14-,15-,17+,18-,19-,21-,22+,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
2.5n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125688
PNG
(3-hydroxy-6-[10-hydroxy-4-methyl-(5R,13R,14S,17R)-...)
Show SMILES CN1CCC23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4OC1OC(C(O)C=C1)C(O)=O)ccc5O |c:16,26,THB:0:1:12:8.9.10|
Show InChI InChI=1S/C23H25NO7/c1-24-9-8-23-12-3-6-16(29-17-7-5-15(26)20(30-17)22(27)28)21(23)31-19-14(25)4-2-11(18(19)23)10-13(12)24/h2-7,12-13,15-17,20-21,25-26H,8-10H2,1H3,(H,27,28)/t12-,13+,15?,16-,17?,20?,21-,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
3.20n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451819
PNG
(CHEMBL2079659)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2OC1OC(CO)[C@H](O)C(O)C1O)ccc3O |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C23H29NO8/c1-24-7-6-23-11-3-5-14(30-22-19(29)18(28)17(27)15(9-25)31-22)21(23)32-20-13(26)4-2-10(16(20)23)8-12(11)24/h2-5,11-12,14-15,17-19,21-22,25-29H,6-9H2,1H3/t11-,12+,14-,15?,17-,18?,19?,21-,22?,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
3.20n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL




Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451823
PNG
(CHEMBL2112840)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(CC6CC6)CCC14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:23,THB:3:4:17:9.15.14,10:9:17:4.5.6|
Show InChI InChI=1S/C26H31NO9/c28-15-5-3-12-9-14-13-4-6-16(34-25-20(31)18(29)19(30)22(36-25)24(32)33)23-26(13,17(12)21(15)35-23)7-8-27(14)10-11-1-2-11/h3-6,11,13-14,16,18-20,22-23,25,28-31H,1-2,7-10H2,(H,32,33)/t13-,14+,16-,18-,19-,20-,22+,23-,25+,26?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
3.5n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451824
PNG
(CHEMBL2092968)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])C=C[C@@H]2OC1OC(CO)[C@H](O)C(O)C1O)ccc3O |c:19,THB:3:4:14:9.12.11,10:9:14:4.5.6|
Show InChI InChI=1S/C23H29NO8/c1-24-7-6-23-11-3-5-14(30-22-19(29)18(28)17(27)15(9-25)31-22)21(23)32-20-13(26)4-2-10(16(20)23)8-12(11)24/h2-5,11-12,14-15,17-19,21-22,25-29H,6-9H2,1H3/t11-,12+,14-,15?,17-,18?,19?,21-,22?,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
4.80n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50000092
PNG
((-)-(etorphine) | (-)-morphine | (1S,5R,13R,14S)-1...)
Show SMILES CN1CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4O)ccc5O |r,c:16,TLB:13:12:8.9.10:3.2.1|
Show InChI InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
KEGG
MMDB
PC cid
PC sid
PDB
UniChem

Patents

PubMed
4.80n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL




Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451822
PNG
(CHEMBL2112839)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])CC[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |THB:10:9:14:4.5.6,3:4:14:9.12.11|
Show InChI InChI=1S/C23H29NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2,4,10-11,13,15-17,19-20,22,25-28H,3,5-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17-,19+,20-,22+,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
5.70n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125686
PNG
(2-[10-hydroxy-4-methyl-(5R,13R,14S,17R)-12-oxa-4-a...)
Show SMILES CC1OC(O[C@H]2C=C[C@H]3[C@H]4Cc5ccc(O)c6O[C@@H]2C3(CCN4C)c56)C(O)C(O)C1O |c:6,TLB:23:22:8:24.11.10|
Show InChI InChI=1S/C23H29NO7/c1-10-17(26)18(27)19(28)22(29-10)30-15-6-4-12-13-9-11-3-5-14(25)20-16(11)23(12,21(15)31-20)7-8-24(13)2/h3-6,10,12-13,15,17-19,21-22,25-28H,7-9H2,1-2H3/t10?,12-,13+,15-,17?,18?,19?,21-,22?,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
6.20n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451820
PNG
(CHEMBL3085267)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:21,TLB:10:9:16:4.5.6|
Show InChI InChI=1S/C25H29NO9/c1-2-8-26-9-7-25-12-4-6-15(33-24-19(30)17(28)18(29)21(35-24)23(31)32)22(25)34-20-14(27)5-3-11(16(20)25)10-13(12)26/h2-6,12-13,15,17-19,21-22,24,27-30H,1,7-10H2,(H,31,32)/t12-,13+,15-,17-,18-,19-,21+,22-,24+,25-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
10n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50370478
PNG
(MORPHINE-6-GLUCURONIDE | Morphine 6-Glucuronide(Mi...)
Show SMILES CN1CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)ccc5O |r,c:16|
Show InChI InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
Purchase

KEGG
PC cid
PC sid
UniChem
PubMed
26n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL




Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451821
PNG
(CHEMBL3085275)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(CC(O)=O)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:22,TLB:10:9:17:4.5.6|
Show InChI InChI=1S/C24H27NO11/c26-12-3-1-9-7-11-10-2-4-13(34-23-18(31)16(29)17(30)20(36-23)22(32)33)21-24(10,15(9)19(12)35-21)5-6-25(11)8-14(27)28/h1-4,10-11,13,16-18,20-21,23,26,29-31H,5-8H2,(H,27,28)(H,32,33)/t10-,11+,13-,16-,17-,18-,20+,21-,23+,24-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
33n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125689
PNG
(6-[4-allyl-10-hydroxy-(5R,13R,14S,17R)-12-oxa-4-az...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])NCC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:18|
Show InChI InChI=1S/C22H25NO9/c24-11-3-1-8-7-10-9-2-4-12(19-22(9,5-6-23-10)13(8)17(11)31-19)30-21-16(27)14(25)15(26)18(32-21)20(28)29/h1-4,9-10,12,14-16,18-19,21,23-27H,5-7H2,(H,28,29)/t9-,10+,12-,14-,15-,16-,18+,19-,21+,22-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
37n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451825
PNG
(CHEMBL2113393)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CCC14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)C(O)=O)ccc3O |r,c:19,THB:3:4:14:9.12.11,10:9:14:4.5.6|
Show InChI InChI=1S/C22H25NO8/c1-23-7-6-22-10-3-5-13(29-21-16(26)15(25)18(31-21)20(27)28)19(22)30-17-12(24)4-2-9(14(17)22)8-11(10)23/h2-5,10-11,13,15-16,18-19,21,24-26H,6-8H2,1H3,(H,27,28)/t10-,11+,13-,15-,16+,18-,19-,21+,22?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
44n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125680
PNG
(3,4-dihydroxy-2-[10-hydroxy-4-methyl-(5R,13R,14S,1...)
Show SMILES CN1CCC23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4OC1OC(=CC(O)C1O)C(O)=O)ccc5O |c:16,23,THB:0:1:12:8.9.10|
Show InChI InChI=1S/C23H25NO8/c1-24-7-6-23-11-3-5-15(30-22-18(27)14(26)9-16(31-22)21(28)29)20(23)32-19-13(25)4-2-10(17(19)23)8-12(11)24/h2-5,9,11-12,14-15,18,20,22,25-27H,6-8H2,1H3,(H,28,29)/t11-,12+,14?,15-,18?,20-,22?,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
48n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125692
PNG
(3,4,5-trihydroxy-6-[10-hydroxy-(5R,13R,14S,17R)-12...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2OC1O[C@H](CC(O)C1O)C(O)=O)ccc3O |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C23H27NO8/c1-24-7-6-23-11-3-5-15(30-22-18(27)14(26)9-16(31-22)21(28)29)20(23)32-19-13(25)4-2-10(17(19)23)8-12(11)24/h2-5,11-12,14-16,18,20,22,25-27H,6-9H2,1H3,(H,28,29)/t11-,12+,14?,15-,16+,18?,20-,22?,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
57n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125684
PNG
(3,4,5-trihydroxy-6-[10-methoxy-4-methyl-(5R,13R,14...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3OC |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C24H29NO9/c1-25-8-7-24-11-4-6-14(32-23-18(28)16(26)17(27)20(34-23)22(29)30)21(24)33-19-13(31-2)5-3-10(15(19)24)9-12(11)25/h3-6,11-12,14,16-18,20-21,23,26-28H,7-9H2,1-2H3,(H,29,30)/t11-,12+,14-,16-,17-,18-,20+,21-,23+,24-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
85n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125690
PNG
(6-[10-hydroxy-4-methyl-(5R,13R,14S,17R)-12-oxa-4-a...)
Show SMILES CN1CCC23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4OC1CCCC(O1)C(O)=O)ccc5O |c:16,THB:0:1:12:8.9.10|
Show InChI InChI=1S/C23H27NO6/c1-24-10-9-23-13-6-8-16(28-18-4-2-3-17(29-18)22(26)27)21(23)30-20-15(25)7-5-12(19(20)23)11-14(13)24/h5-8,13-14,16-18,21,25H,2-4,9-11H2,1H3,(H,26,27)/t13-,14+,16-,17?,18?,21-,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
168n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125687
PNG
(2-[14-(6-carboxy-3,4,5-trihydroxytetrahydro-2H-2-p...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@@H](C[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C23H27NO8/c1-24-7-6-23-11-3-5-15(30-22-18(27)14(26)9-16(31-22)21(28)29)20(23)32-19-13(25)4-2-10(17(19)23)8-12(11)24/h2-5,11-12,14-16,18,20,22,25-27H,6-9H2,1H3,(H,28,29)/t11-,12+,14-,15-,16-,18-,20-,22+,23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
172n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125688
PNG
(3-hydroxy-6-[10-hydroxy-4-methyl-(5R,13R,14S,17R)-...)
Show SMILES CN1CCC23[C@H]4Oc5c2c(C[C@@H]1[C@@H]3C=C[C@@H]4OC1OC(C(O)C=C1)C(O)=O)ccc5O |c:16,26,THB:0:1:12:8.9.10|
Show InChI InChI=1S/C23H25NO7/c1-24-9-8-23-12-3-6-16(29-17-7-5-15(26)20(30-17)22(27)28)21(23)31-19-14(25)4-2-11(18(19)23)10-13(12)24/h2-7,12-13,15-17,20-21,25-26H,8-10H2,1H3,(H,27,28)/t12-,13+,15?,16-,17?,20?,21-,23?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
178n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL




Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50451821
PNG
(CHEMBL3085275)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(CC(O)=O)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3O |c:22,TLB:10:9:17:4.5.6|
Show InChI InChI=1S/C24H27NO11/c26-12-3-1-9-7-11-10-2-4-13(34-23-18(31)16(29)17(30)20(36-23)22(32)33)21-24(10,15(9)19(12)35-21)5-6-25(11)8-14(27)28/h1-4,10-11,13,16-18,20-21,23,26,29-31H,5-8H2,(H,27,28)(H,32,33)/t10-,11+,13-,16-,17-,18-,20+,21-,23+,24-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
1.62E+3n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Nociceptin/mu opioid receptor


(Rattus norvegicus (rat))
BDBM50125684
PNG
(3,4,5-trihydroxy-6-[10-methoxy-4-methyl-(5R,13R,14...)
Show SMILES [H][C@@]12Oc3c4c(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O)C(O)=O)ccc3OC |c:19,THB:10:9:14:4.5.6|
Show InChI InChI=1S/C24H29NO9/c1-25-8-7-24-11-4-6-14(32-23-18(28)16(26)17(27)20(34-23)22(29)30)21(24)33-19-13(31-2)5-3-10(15(19)24)9-12(11)25/h3-6,11-12,14,16-18,20-21,23,26-28H,7-9H2,1-2H3,(H,29,30)/t11-,12+,14-,16-,17-,18-,20+,21-,23+,24-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
5.70E+3n/an/an/an/an/an/an/an/a



Ultrafine UFC Ltd

Curated by ChEMBL


Assay Description
mu-2 receptor binding affinity in rat brain by 3H [d-Ala2, (N-Me)Phe4, Gly5-ol] enkephalin displacement.


Bioorg Med Chem Lett 13: 1207-14 (2003)


BindingDB Entry DOI: 10.7270/Q2251JQC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Mus musculus (Mouse))
BDBM50437408
PNG
(CHEMBL2408790 | US9023865, 2)
Show SMILES COc1cccc(F)c1CN1CCC[C@H](C1)NC(=O)Nc1cc2[nH]nc(-c3ccnc(C)c3)c2cn1 |r|
Show InChI InChI=1S/C26H28FN7O2/c1-16-11-17(8-9-28-16)25-19-13-29-24(12-22(19)32-33-25)31-26(35)30-18-5-4-10-34(14-18)15-20-21(27)6-3-7-23(20)36-2/h3,6-9,11-13,18H,4-5,10,14-15H2,1-2H3,(H,32,33)(H2,29,30,31,35)/t18-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
US Patent
n/an/a 0.152n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Mus musculus (Mouse))
BDBM50437407
PNG
(CHEMBL2408789 | US9023865, 6)
Show SMILES C[C@@H](NC(=O)Nc1cc2[nH]nc(-c3ccnc(C)c3)c2cn1)c1ccccc1 |r|
Show InChI InChI=1S/C21H20N6O/c1-13-10-16(8-9-22-13)20-17-12-23-19(11-18(17)26-27-20)25-21(28)24-14(2)15-6-4-3-5-7-15/h3-12,14H,1-2H3,(H,26,27)(H2,23,24,25,28)/t14-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
US Patent
n/an/a 0.152n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Mus musculus (Mouse))
BDBM157165
PNG
(US9023865, 11)
Show SMILES C[C@H](NC(=O)Nc1cc2[nH]nc(-c3ccnc(C)c3)c2cn1)c1ccc(F)cc1 |r|
Show InChI InChI=1/C21H19FN6O/c1-12-9-15(7-8-23-12)20-17-11-24-19(10-18(17)27-28-20)26-21(29)25-13(2)14-3-5-16(22)6-4-14/h3-11,13H,1-2H3,(H,27,28)(H2,24,25,26,29)/t13-/s2
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.152n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM157642
PNG
(US9023865, 483)
Show SMILES Cc1cc(ccn1)-c1n[nH]c2cc(NC(=O)N[C@H](CN)c3ccccc3)ncc12 |r|
Show InChI InChI=1/C21H21N7O/c1-13-9-15(7-8-23-13)20-16-12-24-19(10-17(16)27-28-20)26-21(29)25-18(11-22)14-5-3-2-4-6-14/h2-10,12,18H,11,22H2,1H3,(H,27,28)(H2,24,25,26,29)/t18-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.152n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM157225
PNG
(US9023865, 71)
Show SMILES C[C@@H](NC(=O)Nc1cc2[nH]nc(-c3ccc(=O)n(C)c3)c2cn1)c1ccc(F)cc1 |r|
Show InChI InChI=1/C21H19FN6O2/c1-12(13-3-6-15(22)7-4-13)24-21(30)25-18-9-17-16(10-23-18)20(27-26-17)14-5-8-19(29)28(2)11-14/h3-12H,1-2H3,(H,26,27)(H2,23,24,25,30)/t12-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.159n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM157778
PNG
(US9023865, 619)
Show SMILES Cc1cc(ccn1)-c1n[nH]c2cc(NC(=O)NCc3cccc(c3)S(C)(=O)=O)ncc12
Show InChI InChI=1S/C21H20N6O3S/c1-13-8-15(6-7-22-13)20-17-12-23-19(10-18(17)26-27-20)25-21(28)24-11-14-4-3-5-16(9-14)31(2,29)30/h3-10,12H,11H2,1-2H3,(H,26,27)(H2,23,24,25,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.159n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM157343
PNG
(US9023865, 184)
Show SMILES CN1C[C@@H](NC(=O)Nc2cc3[nH]nc(-c4ccnc(C)c4)c3cn2)[C@@H](C1)c1ccccc1F |r|
Show InChI InChI=1/C24H24FN7O/c1-14-9-15(7-8-26-14)23-17-11-27-22(10-20(17)30-31-23)29-24(33)28-21-13-32(2)12-18(21)16-5-3-4-6-19(16)25/h3-11,18,21H,12-13H2,1-2H3,(H,30,31)(H2,27,28,29,33)/t18-,21+/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.171n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM157706
PNG
(US9023865, 547)
Show SMILES COC[C@@H](NC(=O)Nc1ncc2c(n[nH]c2c1F)-c1ccncc1)c1ccccc1 |r|
Show InChI InChI=1/C21H19FN6O2/c1-30-12-16(13-5-3-2-4-6-13)25-21(29)26-20-17(22)19-15(11-24-20)18(27-28-19)14-7-9-23-10-8-14/h2-11,16H,12H2,1H3,(H,27,28)(H2,24,25,26,29)/t16-/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.184n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM157739
PNG
(US9023865, 580)
Show SMILES Cc1cc(ccn1)-c1n[nH]c2cc(NC(=O)N[C@@H]3COC[C@H]3c3ccccc3)ncc12 |r|
Show InChI InChI=1/C23H22N6O2/c1-14-9-16(7-8-24-14)22-17-11-25-21(10-19(17)28-29-22)27-23(30)26-20-13-31-12-18(20)15-5-3-2-4-6-15/h2-11,18,20H,12-13H2,1H3,(H,28,29)(H2,25,26,27,30)/t18-,20+/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.193n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Mus musculus (Mouse))
BDBM272794
PNG
(6-bromo-3-(2-methylpyridin-4-yl)-1,8-dihydro-7H-py...)
Show SMILES Cc1cc(ccn1)-c1n[nH]c2cc3[nH]c(=O)c(Br)cc3cc12
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent




US Patent US9745307 (2017)


BindingDB Entry DOI: 10.7270/Q28G8NTK
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Mus musculus (Mouse))
BDBM272795
PNG
(6-benzyl-3-(2-methylpyridin-4-yl)-1,8-dihydro-7H-p...)
Show SMILES Cc1cc(ccn1)-c1n[nH]c2cc3[nH]c(=O)c(Cc4ccccc4)cc3cc12
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent




US Patent US9745307 (2017)


BindingDB Entry DOI: 10.7270/Q28G8NTK
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM50437407
PNG
(CHEMBL2408789 | US9023865, 6)
Show SMILES C[C@@H](NC(=O)Nc1cc2[nH]nc(-c3ccnc(C)c3)c2cn1)c1ccccc1 |r|
Show InChI InChI=1S/C21H20N6O/c1-13-10-16(8-9-22-13)20-17-12-23-19(11-18(17)26-27-20)25-21(28)24-14(2)15-6-4-3-5-7-15/h3-12,14H,1-2H3,(H,26,27)(H2,23,24,25,28)/t14-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
US Patent
n/an/a 0.204n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Mus musculus (Mouse))
BDBM157164
PNG
(US9023865, 10)
Show SMILES Cc1cc(ccn1)-c1n[nH]c2cc(NC(=O)NC(CO)c3ccccc3)ncc12
Show InChI InChI=1/C21H20N6O2/c1-13-9-15(7-8-22-13)20-16-11-23-19(10-17(16)26-27-20)25-21(29)24-18(12-28)14-5-3-2-4-6-14/h2-11,18,28H,12H2,1H3,(H,26,27)(H2,23,24,25,29)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.215n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM157340
PNG
(BDBM157741 | US9023865, 181)
Show SMILES CN1C[C@@H](NC(=O)Nc2cc3[nH]nc(-c4ccnc(C)c4)c3cn2)[C@@H](C1)c1ccccc1 |r|
Show InChI InChI=1/C24H25N7O/c1-15-10-17(8-9-25-15)23-18-12-26-22(11-20(18)29-30-23)28-24(32)27-21-14-31(2)13-19(21)16-6-4-3-5-7-16/h3-12,19,21H,13-14H2,1-2H3,(H,29,30)(H2,26,27,28,32)/t19-,21+/s2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.217n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9023865 (2015)


BindingDB Entry DOI: 10.7270/Q2PN94CC
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 2251 total )  |  Next  |  Last  >>
Jump to: